The Food and Drug Administration approved a vaccine from GlaxoSmithKline Plc for use in the event of an H5N1 bird flu epidemic. The vaccine will not be available for commercial use and is approved for people over the age of 18.
NOT FOR REPRINT
FDA approves bird flu vaccine for national stockpile
By
staff Writer
November 24, 2013 at 06:51 PM
Share & Print
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
